IPO Issue Details
Issue Price / Price Band₹135 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,000 Shares per Lot
Total Issue Size36,49,000 shares (aggregating up to ₹49.26 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenThu, 25 Sep 2025
Subscription CloseMon, 29 Sep 2025
Anchor AllotmentWed, 24 Sep 2025
Basis of AllotmentTue, 30 Sep 2025
Initiation of RefundsWed, 01 Oct 2025
Credit of Shares to DematWed, 01 Oct 2025
Listing DateFri, 03 Oct 2025
UPI Mandate Deadline2025-09-29
Application & Investment Details
Retail — Min (2 Lots)₹2,70,000 — 2,000 shares
Retail — Max (13 Lots)₹1,755,000 (13 Lots)
HNI — Min (3 Lots)₹4,05,000 — 3,000 shares
EPS (Pre-IPO)₹6.59
EPS (Post-IPO)₹5.00
P/E Ratio (Pre-IPO)20.48x
P/E Ratio (Post-IPO)26.98x
Net Offer to Public34,64,000 shares (aggregating up to ₹46.76 Cr)
Reserved for Market Maker1,85,000 shares (aggregating up to ₹2.50 Cr)
Pre-IPO Promoter Holding1,04,38,932 shares
Post-IPO Promoter Holding1,37,53,932 shares
Fresh Issue Shares31,30,000 shares (aggregating up to ₹42.26 Cr)
Offer for Sale Shares3,34,000 shares of ₹10 (aggregating up to ₹4.51 Cr)
About Earkart Ltd
Earkart Limited is a HealthTech platform, specializing in hearing aids and related accessories. It offers modern hearing devices, like Receiver-In-Canal (RIC), Invisible (IIC), Behind-The-Ear (BTE), In-The-Ear (ITE), In-The-Canal (ITC) and Completely-In-Canal (CIC).It also offers and distributes other products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) for physically challenged.The company sells products through a network of partners and clinics, both domestically and globally. It is also a trusted Government e-Market (GeM) supplier of hearing aids to ALIMCO under Ministry of Social Justice and Empowerment.In April 2024, the company has launched Shop in Shop (SIS) model, wherein it offers franchise to opticians and ENT/optical clinics. As on date, the company operates 49 SIS clinics across 22 cities in 6 states and 2 Union Territories, i.e., Haryana, Uttar Pradesh, Rajasthan, Punjab, Jharkhand, Delhi, Uttarakhand, and Chandigarh.Its manufacturing facility is located in Noida, across 4,500 square feetCompetitive Strengths:Various types of hearing aids productsMulti-channel product distribution network: Online, offline, and B2G salesContinued focus on innovation and technology
Objects of the Issue
Earkart Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding incremental working capital requirements of our Company
21.10
2
Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities
17.33
3
General Corporate Purposes
0.63
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,04,38,932 shares
Post-IPO Promoter Holding
1,37,53,932 shares